- Home
- RCKT vs PRAA Comparison
RCKT vs PRAA Comparison
Compare RCKT & PRAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- PRAA
- Stock Information
- Founded
- RCKT 1999
- PRAA 1996
- Country
- RCKT United States
- PRAA United States
- Employees
- RCKT N/A
- PRAA N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- PRAA Finance: Consumer Services
- Sector
- RCKT Health Care
- PRAA Finance
- Exchange
- RCKT Nasdaq
- PRAA Nasdaq
- Market Cap
- RCKT 764.5M
- PRAA 790.6M
- IPO Year
- RCKT N/A
- PRAA N/A
- Fundamental
- Price
- RCKT $2.77
- PRAA $14.05
- Analyst Decision
- RCKT Buy
- PRAA Strong Buy
- Analyst Count
- RCKT 11
- PRAA 2
- Target Price
- RCKT $21.77
- PRAA $27.00
- AVG Volume (30 Days)
- RCKT 7.4M
- PRAA 756.0K
- Earning Date
- RCKT 05-08-2025
- PRAA 05-05-2025
- Dividend Yield
- RCKT N/A
- PRAA N/A
- EPS Growth
- RCKT N/A
- PRAA N/A
- EPS
- RCKT N/A
- PRAA 1.79
- Revenue
- RCKT N/A
- PRAA $1,128,557,000.00
- Revenue This Year
- RCKT N/A
- PRAA $2.73
- Revenue Next Year
- RCKT N/A
- PRAA $7.34
- P/E Ratio
- RCKT N/A
- PRAA $7.94
- Revenue Growth
- RCKT N/A
- PRAA 25.02
- 52 Week Low
- RCKT $2.19
- PRAA $12.91
- 52 Week High
- RCKT $26.98
- PRAA $27.54
- Technical
- Relative Strength Index (RSI)
- RCKT 27.94
- PRAA 39.39
- Support Level
- RCKT $2.19
- PRAA $13.22
- Resistance Level
- RCKT $2.67
- PRAA $14.37
- Average True Range (ATR)
- RCKT 0.54
- PRAA 0.57
- MACD
- RCKT -0.45
- PRAA 0.09
- Stochastic Oscillator
- RCKT 11.72
- PRAA 31.44
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About PRAA PRA Group Inc.
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.